
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Endocrinol., 06 August 2024
Sec. Obesity
Volume 15 - 2024 | https://doi.org/10.3389/fendo.2024.1460652
This article is part of the Research TopicAdvances in the Research of Diabetic Nephropathy Volume IIIView all 5 articles
A retraction of this article was approved in:
Retraction: Mendelian randomization based on immune cells in diabetic nephropathy
Citation: Zhou Y, Zhang H, Yan H, Huang C and Liu Y (2024) Mendelian randomization based on immune cells in diabetic nephropathy. Front. Endocrinol. 15:1460652. doi: 10.3389/fendo.2024.1460652
Received: 06 July 2024; Accepted: 22 July 2024;
Published: 06 August 2024; Retracted: 19 February 2025.
Edited by:
Yun Shen, Pennington Biomedical Research Center, United StatesReviewed by:
Yi Mu, ClinChoice Inc, United StatesDisclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.